Home > Dermatology > EADV 2019 > Letter from the Editor

Letter from the Editor

Prof. Peter C.M. van de Kerkhof, Radboud University Nijmegen
EADV 2019
Dear Reader, The 28th EADV Congress brought innovations to dermatologists in many respects. In this overview, we have attempted to be balanced and to focus on the presentations which are practically relevant. The new insights into the pathogenesis of inflammatory skin diseases have provided biomarkers that are becoming significant to dermatology. Introduction of new treatments in inflammatory dermatoses requires a critical and adequate positioning of new treatments in daily practice. In particular in psoriasis, the innovations found their way to real clinical practice: In children with psoriasis anti-IL-17 are currently explored. On ixekizumab, 78% of children with psoriasis reached a PASI 90 response. Comorbidities are also relevant to psoriasis. Studies...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on